参考文献/References:
[1]Meltzer PS,Helman LJ.New Horizonsin the Treatment of Osteosarcoma[J].N Engl J Med,2021,385(22):2066-2076.[2]Zhang K,Dong C,Chen M,et al.Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma[J].Theranostics,2020,10(1):411-425.[3]姜爽,徐婧瑶,苏鑫,等.山慈菇多糖的免疫调节作用及对小鼠骨肉瘤细胞S180体内生长抑制作用[J].食品科学,2018,39(6):216-221.[4]洪嵩,蔡东峰,张靖,等.miR-552靶向调控Wnt抑制因子-1促进MG-63骨肉瘤细胞增殖、侵袭、迁移的实验研究[J].临床肿瘤学杂志,2019,24(6):494-499.[5]范兆阳,鲜文峰,刘永喜,等.石斛酚通过NF-κB/PRL-3通路抑制骨肉瘤细胞增殖、迁移和侵袭[J].中国肿瘤生物治疗杂志,2019,26(10):1095-1100.[6]郑颖,王刚阳,陈瑞玲,等.探讨鸦胆子素D对骨肉瘤细胞增殖、凋亡与自噬的作用[J].中国骨与关节杂志,2017,6(6):433-438.[7]杜兵强,张伟霞,张连平.槲寄生素对人骨肉瘤U20S细胞的抑制及对PI3K/Akt/mTOR通路的调控作用[J].中医学报,2020,35(2):323-329.[8]宋建治,孙智珺.石见穿多糖增强γδT细胞对骨肉瘤细胞的杀伤作用[J].免疫学杂志,2020,36(12):1053-1058.[9]赵红兵,张喜凤.CT引导下穿刺活检诊断软骨肉瘤25例[J].新乡医学院学报,2007,24(2):177-178.[10]王志远,梅炯,陈雁西,等.肢体骨肿瘤活检失误临床分析[J].同济大学学报(医学版),2009,30(1):73-76,84.[11]谢晓飞,高艺博,邵哲.血清miR-223、miR-148a联合检测用于骨肉瘤临床诊断及预后评估价值分析[J].医学理论与实践,2022,35(6):1031-1034.[12]肖鑫,王臻,许骋,等.基于高通量测序技术的骨肉瘤基因研究与个体化治疗[J].中华骨科杂志,2014,34(4):466-471.[13]崔胜宏,杨兴亮,田娟,等.骨肉瘤的X线CT及MRI检查分析[J].安徽医学,2012,33(3):319-321.[14]陈海妹.基于MRI影像组学的骨肉瘤新辅助化疗疗效及预后预测的研究[D].广州:南方医科大学,2021.[15]牛晓辉,王洁,孙燕,等.经典型骨肉瘤临床诊疗专家共识[J].临床肿瘤学杂志,2012,17(10):931-933.[16]尹诗源,李雨晴,尹玉,等.探讨骨肉瘤化疗耐药中FoxM1与c-myc的关系及其作用机制[J].临床与实验病理学杂志,2023,39(2):195-200.[17]郭卫.肢体恶性骨肿瘤保肢治疗的方法及原则[J].北京大学学报(医学版),2012,44(6):824-827.[18]唐彬淞,郭建平,于苗,等.新辅助化疗联合保肢手术治疗青少年骨肉瘤的临床疗效[J].北华大学学报(自然科学版),2022,23(4):514-517.[19]牛晓颖,高世磊,屈国新,等.3D打印假体在治疗青少年股骨恶性肿瘤大段骨缺损重建中保留骨骺及关节面的应用[J].中国修复重建外科杂志,2022,11(36):1-7.[20]李伟,沙丹,马春燕.融合自杀基因抑骨肉瘤生长的实验研究[J].华中医学杂志,2009,33(1):1-5,23.[21]岑超德,张永,罗聪,等.超顺磁性聚乙烯亚胺纳米粒的制备及其骨肉瘤细胞、组织靶向转染效果观察[J].山东医药,2021,61(8):15-19.[22]Fernandes I,Melo-Alvim C,Lopes-Bras R,et al.Osteosarcoma Pathogenesis Leads the Way to New Target Treatments[J].International Journal of Molecular Sciences,2021,22(2):813.[23]Cui JC,Wang WC,Li ZH,et al.Epigenetic changes in osteosarcoma[J].Bulletin Du Cancer,2011,98(7):E62-E68.[24]Li HM,He YK,Hao P,et al.Identification of characteristic gene modules of osteosarcoma using bioinformatics analysis indicates the possible molecular pathogenesis[J].Molecular Medicine Reports,2017,15(4):2113-2119.[25]Zhao X,Yang Y,Xu J,et al.Downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression[J].Oncol Rep,2018,39(1):289-297.[26]Li S,Gao Y,Wang Y,et al.Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma[J].Oncol Lett,2016,12(6):4905-4910.[27]He JY,Ling L,Liu ZY,et al.Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma[J].Cancer Cell International,2021,21(1):313.[28]Yao Q,Chen T.LINC01128 regulates the development of osteosarcoma by sponging miR-299-3p to mediate MMP2 expression and activating Wnt/β-catenin signalling pathway[J].J Cell Mol Med,2020,24(24):14293-14305.[29]Zhang RM,Tang T,Yu HM,et al.LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling[J].Biochem Biophys Res Commun,2018,507(1-4):260-266.[30]Wang Y,Shi S,Zhang Q,et al.MicroRNA-206 upregulation relieves circTCF25-induced osteosarcoma cell proliferation and migration[J].Journal of Cellular Physiology,2020,(2):1097-4652.[31]Isakoff MS, Bielack SS,Meltzer P,et al.Osteosarcoma: Current Treatment and a Collaborative Pathway to Success[J].J Clin Oncol,2015,33(27):3029-3035.[32]Yu L,Zhang J,Li YF.Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality[J].Frontiers In Immunology,2022,13(8):871076.[33]Yoshida K,Okamoto M,Aoki K,et al.A Review of T-Cell Related Therapy for Osteosarcoma[J].Int J Mol Sci,2020,21(14):4877[34]Hirabayashi H,Fujisaki J.Bone-specific drug delivery systems-Approaches via chemical modification of bone-seeking agents[J].Clinical Pharmacokinetics,2003,42(15):1319-1330.[35]Quadros M,Momin M,Verma G.Design strategies and evolving role of biomaterial assisted treatment of osteosarcoma[J].Materials Science And Engineering C-materials for Biological Applications,2021,121:111875.
相似文献/References:
[1]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Journal of Medical Information,2018,31(06):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[2]苏 志,吴 蔚,吴智钢,等.含洛铂方案新辅助化疗结合保肢手术治疗骨肉瘤的临床疗效观察[J].医学信息,2018,31(21):83.[doi:10.3969/j.issn.1006-1959.2018.21.022]
SU Zhi,WU Wei,WU Zhi-gang,et al.Clinical Efficacy of Neoadjuvant Chemotherapy with Lobaplatin Combined with Limb Salvage Surgery for OsteosarcomaC[J].Journal of Medical Information,2018,31(06):83.[doi:10.3969/j.issn.1006-1959.2018.21.022]
[3]林夏妃,吴海霞,随燕芳,等.2009~2018年癌症康复研究的CiteSpace科学知识图谱可视化分析[J].医学信息,2020,33(02):1.[doi:10.3969/j.issn.1006-1959.2020.02.001]
LIN Xia-fei,WU Hai-xia,SUI Yan-fang,et al.Visual Analysis of CiteSpace Scientific Knowledge Map for Cancer Rehabilitation Research from 2009 to 2018[J].Journal of Medical Information,2020,33(06):1.[doi:10.3969/j.issn.1006-1959.2020.02.001]
[4]王 瑞,原志芳,沈悦好,等.基于CiteSpace的国内呼吸系统护理研究热点与前沿的可视化分析[J].医学信息,2020,33(10):1.[doi:10.3969/j.issn.1006-1959.2020.10.001]
WANG Rui,YUAN Zhi-fang,SHEN Yue-hao,et al.Visual Analysis of Hotspots and Frontiers of Domestic Respiratory System Nursing Research Based on CiteSpace[J].Journal of Medical Information,2020,33(06):1.[doi:10.3969/j.issn.1006-1959.2020.10.001]
[5]张士成,王 雪,刘君涵,等.基于文献计量与CiteSpace的国内叙事医学研究热点与进展趋势分析[J].医学信息,2022,35(21):9.[doi:10.3969/j.issn.1006-1959.2022.21.003]
ZHANG Shi-cheng,WANG Xue,LIU Jun-han,et al.Analysis of Research Hotspots and Progress Trends of Domestic Narrative Medicine Based on Bibliometrics and CiteSpace[J].Journal of Medical Information,2022,35(06):9.[doi:10.3969/j.issn.1006-1959.2022.21.003]
[6]徐鋆娴,谢晓云.基于CiteSpace的老年糖尿病护理研究的可视化分析[J].医学信息,2020,33(23):1.[doi:10.3969/j.issn.1006-1959.2020.23.001]
XU Jun-xian,XIE Xiao-yun.Visualization Analysis of Elderly Diabetes Nursing Research Based on CiteSpace[J].Journal of Medical Information,2020,33(06):1.[doi:10.3969/j.issn.1006-1959.2020.23.001]
[7]陆柔凤,葛 微.鼻咽癌影响因素研究热点与前沿分析[J].医学信息,2022,35(22):34.[doi:10.3969/j.issn.1006-1959.2022.22.006]
LU Rou-feng,GE Wei.Research Focus and Frontier Analysis of Influencing Factors of Nasopharyngeal Carcinoma[J].Journal of Medical Information,2022,35(06):34.[doi:10.3969/j.issn.1006-1959.2022.22.006]
[8]徐安迎,魏海斌,陈丽蓉,等.基于CiteSpace的我国医德医风建设研究热点与演化趋势的可视化计量分析[J].医学信息,2021,34(06):20.[doi:10.3969/j.issn.1006-1959.2021.06.006]
XU An-ying,WEI Hai-bin,CHEN Li-rong,et al.Visual Metrological Analysis of Research Hotspots and Evolutionary Trends of China’s Medical Ethics and Style Construction Based on CiteSpace[J].Journal of Medical Information,2021,34(06):20.[doi:10.3969/j.issn.1006-1959.2021.06.006]
[9]翁梦晴,韦彩萍,任文宁,等.基于CiteSpace的人乳头瘤病毒疫苗可视化分析[J].医学信息,2023,36(03):39.[doi:10.3969/j.issn.1006-1959.2023.03.009]
WENG Meng-qing,WEI Cai-ping,REN Wen-ning,et al.Visual Analysis of Human Papillomavirus Vaccine Based on CiteSpace[J].Journal of Medical Information,2023,36(06):39.[doi:10.3969/j.issn.1006-1959.2023.03.009]
[10]刘 萍,张嘉鹏.基于知识图谱的MIMIC电子病历数据集的研究热点和趋势分析[J].医学信息,2023,36(07):67.[doi:10.3969/j.issn.1006-1959.2023.07.012]
LIU Ping,ZHANG Jia-peng.Research Hotspots and Trend Analysis of MIMIC Electronic Medical Record Data Set Based on Knowledge Graph[J].Journal of Medical Information,2023,36(06):67.[doi:10.3969/j.issn.1006-1959.2023.07.012]